Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03487822 · ClinicalTrials.gov registry record · NA

A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions

A NA study of Pain, Chronic and Negative Emotions, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
157
Enrollment target
1
Study location

NCT03487822 is a NA study of Pain, Chronic and Negative Emotions that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 157 participants, below the 718-participant average among 48 other Pain, Chronic trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03487822, a NA study of Pain, Chronic and Negative Emotions, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
157 participants
Enrollment target
1
Study location

Study Summary

This study examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. Half the participants will receive the intervention, and half the participants will receive usual care with education. Intervention subjects are hypothesized to have significantly less pain-related disability versus usual care subjects after 24 weeks.

Interventions

  • BEHAVIORAL Path Pain

Study Locations (1)

New York

  • Center on Aging (formerly Wright Center on Aging) - New York

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2017-08-08
Est. Completion 2019-07-26
Phase NA

What the Registry Record Tells You About NCT03487822

The ClinicalTrials.gov registry entry for NCT03487822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 718-participant average among 48 other Pain, Chronic trials with a reported enrollment target (78% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Path Pain is the first listed.

NCT03487822 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03487822 about?

NCT03487822 is a clinical study titled "A Personalized Self-Management Program for Older Adults With Chronic Pain and Negative Emotions". This study examines the effects of PATH-Pain on emotion regulation to improve self-management of pain and pain-related disability in older adults with chronic pain, negative emotions, and cognitive impairment. Half the participants will receive the intervention, and half the participants will receiv...

What is the current status of trial NCT03487822?

This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2017-08-08. Estimated completion is 2019-07-26.

What conditions does trial NCT03487822 study?

This clinical trial studies the following conditions: Pain, Chronic, Negative Emotions.

What interventions are being tested in trial NCT03487822?

The interventions under investigation include: Path Pain (BEHAVIORAL).

Who is sponsoring clinical trial NCT03487822?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03487822 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.